Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 2003 Feb 15;370(Pt 1):323–329. doi: 10.1042/BJ20021238

Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.

Douglas Vernimmen 1, Dominique Begon 1, Christophe Salvador 1, Stéphanie Gofflot 1, Madeleine Grooteclaes 1, Rosita Winkler 1
PMCID: PMC1223148  PMID: 12418962

Abstract

The ERBB2 gene is overexpressed in 30% of human breast cancers and this is correlated with poor prognosis. Overexpression of the ERBB2 gene is due to increased transcription and gene amplification. Our previous studies have identified a new cis element in the ERBB2 promoter which is involved in the gene's overexpression. This cis element, located 501 bp upstream from the main ERBB2 transcription initiation site, binds a transcription factor called HTF (HER2 transcription factor). We report here the identification of HTF as an AP-2 (activator protein-2) transcription factor. The new cis element is bound by AP-2 with high affinity, compared with a previously described AP-2 binding site located 284 bp downstream. Co-transfection of an AP-2alpha expression vector with a reporter vector containing the newly identified AP-2 binding site in front of a minimal ERBB2 promoter induced a dose-dependent increase in transcriptional activity. We examined the contribution of the new AP-2 binding site to ERBB2 overexpression. For this purpose we abolished the new and/or the previously described AP-2 binding sequence by site-directed mutagenesis. The results show that the two functional AP-2 sites in the first 700 bp of the ERBB2 promoter co-operate to achieve maximal transcriptional activity.

Full Text

The Full Text of this article is available as a PDF (236.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bates N. P., Hurst H. C. Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland. J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):153–163. doi: 10.1023/a:1026303814855. [DOI] [PubMed] [Google Scholar]
  2. Bosher J. M., Totty N. F., Hsuan J. J., Williams T., Hurst H. C. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene. 1996 Oct 17;13(8):1701–1707. [PubMed] [Google Scholar]
  3. Bosher J. M., Williams T., Hurst H. C. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):744–747. doi: 10.1073/pnas.92.3.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cheng Chao, Ying Kang, Xu Ming, Zhao Wei, Zhou Zongxiang, Huang Yan, Wang Wei, Xu Jian, Zeng Li, Xie Yi. Cloning and characterization of a novel human transcription factor AP-2 beta like gene (TFAP2BL1). Int J Biochem Cell Biol. 2002 Jan;34(1):78–86. doi: 10.1016/s1357-2725(01)00098-x. [DOI] [PubMed] [Google Scholar]
  5. Gee J. M., Robertson J. F., Ellis I. O., Nicholson R. I., Hurst H. C. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J Pathol. 1999 Dec;189(4):514–520. doi: 10.1002/(SICI)1096-9896(199912)189:4<514::AID-PATH463>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  6. Grooteclaes M., Pasleau F., Dijkmans H., Berzi P., Albert A., Winkler-Gol R. The 6-kilobase c-erbB2 promoter contains positive and negative regulatory elements functional in human mammary cell lines. Cancer Res. 1994 Aug 1;54(15):4193–4199. [PubMed] [Google Scholar]
  7. Grooteclaes M., Vernimmen D., Plaza S., Pasleau F., Hodzic D., Winkler-Gol R. A new cis element is involved in the HER2 gene overexpression in human breast cancer cells. Cancer Res. 1999 Jun 1;59(11):2527–2531. [PubMed] [Google Scholar]
  8. Hilger-Eversheim K., Moser M., Schorle H., Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene. 2000 Dec 30;260(1-2):1–12. doi: 10.1016/s0378-1119(00)00454-6. [DOI] [PubMed] [Google Scholar]
  9. Hollywood D. P., Hurst H. C. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines. EMBO J. 1993 Jun;12(6):2369–2375. doi: 10.1002/j.1460-2075.1993.tb05891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hurst H. C. Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment. Breast Cancer Res. 2001 Oct 1;3(6):395–398. doi: 10.1186/bcr329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Johnson A. C. Activation of epidermal growth factor receptor gene transcription by phorbol 12-myristate 13-acetate is mediated by activator protein 2. J Biol Chem. 1996 Feb 9;271(6):3033–3038. [PubMed] [Google Scholar]
  12. Lefevre C., Imagawa M., Dana S., Grindlay J., Bodner M., Karin M. Tissue-specific expression of the human growth hormone gene is conferred in part by the binding of a specific trans-acting factor. EMBO J. 1987 Apr;6(4):971–981. doi: 10.1002/j.1460-2075.1987.tb04847.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. LiCalsi C., Christophe S., Steger D. J., Buescher M., Fischer W., Mellon P. L. AP-2 family members regulate basal and cAMP-induced expression of human chorionic gonadotropin. Nucleic Acids Res. 2000 Feb 15;28(4):1036–1043. doi: 10.1093/nar/28.4.1036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McPherson L. A., Weigel R. J. AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs. Nucleic Acids Res. 1999 Oct 15;27(20):4040–4049. doi: 10.1093/nar/27.20.4040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mohibullah N., Donner A., Ippolito J. A., Williams T. SELEX and missing phosphate contact analyses reveal flexibility within the AP-2[alpha] protein: DNA binding complex. Nucleic Acids Res. 1999 Jul 1;27(13):2760–2769. doi: 10.1093/nar/27.13.2760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Richardson B. D., Langland R. A., Bachurski C. J., Richards R. G., Kessler C. A., Cheng Y. H., Handwerger S. Activator protein-2 regulates human placental lactogen gene expression. Mol Cell Endocrinol. 2000 Feb 25;160(1-2):183–192. doi: 10.1016/s0303-7207(99)00209-9. [DOI] [PubMed] [Google Scholar]
  17. Ross J. S., Fletcher J. A. HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol. 1999 Jul;112(1 Suppl 1):S53–S67. [PubMed] [Google Scholar]
  18. Schreiber E., Matthias P., Müller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989 Aug 11;17(15):6419–6419. doi: 10.1093/nar/17.15.6419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Scott G. K., Chang C. H., Erny K. M., Xu F., Fredericks W. J., Rauscher F. J., 3rd, Thor A. D., Benz C. C. Ets regulation of the erbB2 promoter. Oncogene. 2000 Dec 18;19(55):6490–6502. doi: 10.1038/sj.onc.1204041. [DOI] [PubMed] [Google Scholar]
  20. Shachaf C., Skorecki K. L., Tzukerman M. Role of AP2 consensus sites in regulation of rat Npt2 (sodium-phosphate cotransporter) promoter. Am J Physiol Renal Physiol. 2000 Mar;278(3):F406–F416. doi: 10.1152/ajprenal.2000.278.3.F406. [DOI] [PubMed] [Google Scholar]
  21. Turner B. C., Zhang J., Gumbs A. A., Maher M. G., Kaplan L., Carter D., Glazer P. M., Hurst H. C., Haffty B. G., Williams T. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res. 1998 Dec 1;58(23):5466–5472. [PubMed] [Google Scholar]
  22. Vergeer W. P., Sogo J. M., Pretorius P. J., de Vries W. N. Interaction of Ap1, Ap2, and Sp1 with the regulatory regions of the human pro-alpha1(I) collagen gene. Arch Biochem Biophys. 2000 May 1;377(1):69–79. doi: 10.1006/abbi.2000.1760. [DOI] [PubMed] [Google Scholar]
  23. Williams T., Tjian R. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev. 1991 Apr;5(4):670–682. doi: 10.1101/gad.5.4.670. [DOI] [PubMed] [Google Scholar]
  24. Yarden Y., Sliwkowski M. X. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001 Feb;2(2):127–137. doi: 10.1038/35052073. [DOI] [PubMed] [Google Scholar]
  25. Zhao F., Satoda M., Licht J. D., Hayashizaki Y., Gelb B. D. Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem. 2001 Aug 24;276(44):40755–40760. doi: 10.1074/jbc.M106284200. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES